Inflammation

Showing NaN - NaN of 2

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cardiovascular Risk, Chronic Kidney Disease, Inflammation Trial in Worldwide (Ziltivekimab, Placebo (ziltivekimab))

Recruiting
  • Cardiovascular Risk
  • +2 more
  • Birmingham, Alabama
  • +768 more
Dec 23, 2022

Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0109-0012, )

Terminated
  • Inflammation
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +163 more
Sep 3, 2018